Heterozygous deletion of mitotic arrest-deficient protein 1 (MAD1) increases the incidence of tumors in mice

Cancer Research

Volumn 67, Issue 1, 2007, Pages 160-166

  Iwanaga, Yoichi ^a   Chi, Ya Hui ^a   Miyazato, Akiko ^a   Sheleg, Sergey ^a   Haller, Kerstin ^a   Peloponese Jr , Jean Marie ^a   Li, Yan ^a   Ward, Jerrold M ^a   Benezra, Robert ^b   Jeang, Kuan Teh ^a,c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MAD1; VINCRISTINE;

AGING; ANEUPLOIDY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INCIDENCE; CARCINOGENESIS; CONTROLLED STUDY; DEPOLYMERIZATION; EMBRYO MORTALITY; FIBROBLAST; FIBROSARCOMA; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; MITOSIS SPINDLE; MOUSE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TUMOR GROWTH;

AMINO ACID SEQUENCE; ANIMALS; CELL CYCLE PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; GENE DELETION; GENOMIC INSTABILITY; HAPLOIDY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NEOPLASMS, EXPERIMENTAL; NUCLEAR PROTEINS; VINCRISTINE;

EID: 33846428426     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-3326     Document Type: Article

References (35)

1. Rieder CL, Maiato H. Stuck in division or passing through what happens when cells cannot satisfy the spindle assembly checkpoint. Dev Cell 2004;7:637-51.
2. Yuen KW, Montpetit B, Hieter P. The kinetochore and cancer: what's the connection? Curr Opin Cell Biol 2005;17:576-82.
3. Chen RH, Brady DM, Smith D, Murray AW, Hardwick KG. The spindle checkpoint of budding yeast depends on a tight complex between the Mad1 and Mad2 proteins. Mol Biol Cell 1999;10:2607-18.
4. Kops GJ, Weaver BA, Cleveland DW. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 2005;5:773-85.
5. Cahili DP, Lengauer C, Yu J, et al. Mutations of mitotic checkpoint genes in human cancers. Nature 1998;392:300-3.
6. Hanks S, Coleman K, Reid S, et al. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet 2004;36:1159-61.
7. Saeki A, Tamura S, Ito N, et al. Frequent impairment of the spindle assembly checkpoint in hepatocellular carcinoma. Cancer 2002;94:2047-54.
8. Tsukasaki K, Miller CW, Greenspun E, et al. Mutations in the mitotic check point gene. MADIL1, in human cancers. Oncogene 2001;20:3301-5.
9. Wang X, Jin DY, Ng RW, et al. Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. Cancer Res 2002;62:1662-8.
10. Sze KM, Ching YP, Jin DY, Ng IO. Association of MAD2 expression with mitotic checkpoint competence in hepatoma cells. J Biomed Sci 2004;11:920-7.
11. Jin DY, Spencer F, Jeang KT. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 1998;93:81-91.
12. Dai W, Wang Q, Liu T, et al. Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency. Cancer Res 2004;64:440-5.
13. Dobles M, Liberal V, Scott ML, Benezra R, Sorger PK.
14. Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell 2000;101:635-45.
15. Kalitsis P, Earle F, Fowler KJ, Choo KH. Bub3 gene disruption in mice reveals essential mitotic spindle checkpoint function during early embryogenesis. Genes Dev 2000;14:2277-82.
16. Baker DJ, Jeganathan KB, Cameron JD, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet 2004;36:744-9.
17. Michel LS, Liberal V, Chatterjee A, et al. MAD2 haploinsufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 2001;409:355-9.
18. Rao CV, Yang YM, Swamy MV, et al. Colonic tumorigenesis in BubR1+/-ApcMin/+ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability. Proc Natl Acad Sci USA 2005;102:4365-70.
19. Vigneron S, Prieto S, Bernis C, et al. Kinetochore localization of spindle checkpoint proteins: who controls whom? Mol Biol Cell 2004;15:4584-96.
20. Iwanaga Y, Kasai T, Kibler K, Jeang KT. Characterization of regions in hsMAD1 needed for binding hsMAD2. A polymorphic change in an hsMAD1 leucine zipper affects MAD1-2 interaction and spindle checkpoint function. J Biol Chem 2002;277:31005-13.
21. Sauer B. Inducible gene targeting in mice using the Cre/lox system. Methods 1998;14:381-92.
22. Kalitsis P, Fowler KJ, Griffiths B, et al. Increased chromosome instability but not cancer predisposition in haploinsufficient Bub3 mice. Genes Chromosomes Cancer 2005;44:29-36.
23. Ward JM. Lymphomas and leukemias in mice. Exp Toxicol Pathol 2006;57:377-81.
24. Anisimov VN, Zabezhinski MA, Rossolini G, et al. Long-live euthymic BALB/c-nu mice. II: spontaneous tumors and other pathologies. Mech Ageing Dev 2001;122:477-89.
25. Lobert S, Vulevic B, Correia JJ. Interaction of Vinca alkaloids with tubulin: a comparison of vinblustine, vincristine, and vinorelbine. Biochemistry 1996;35:6806-14.
26. Wassmann K, Benezra R. Mad2 transiently associates with an APC/p55Cdc complex during mitosis. Proc Natl Acad Sci USA 1998;95:11193-8.
27. Aardema MJ, Albertini S, Arni P, et al. Aneuploidy: a report of an ECETOC task force. Mutat Res 1998;410:3-79.
28. Haller K, Kibler KV, Kasai T, et al. The N-terminus of rodent and human MAD1 confers species-specific stringency to spindle assembly checkpoint. Oncogene 2006;25:2137-47.
29. Kung AL, Sherwood SW, Schimke RT. Cell line-specific differences in the control of cell cycle progression in the absence of mitosis. Proc Natl Acad Sci U S A 1990;87:9553-7.
30. Rangarajan A, Weinberg RA. Opinion: comparative biology of mouse versus human cells: modelling human cancer in mice. Nat Rev Cancer 2003;3:952-9.
31. Duesberg P, Li R, Fabarius A, Hehlmann R. The chromosomal basis of cancer. Cell Oncol 2005;27:293-318.
32. Heng HH, Stevens JB, Liu G, et al. Stochastic cancer progression driven by non-clonal chromosome aberrations. J Cell Physiol 2006;208:461-72.
33. Coe BP, Lee EH, Chi B, et al. Gain of a region on 7p22.3, containing MAD1L1, is the most frequent event in small-cell lung cancer cell lines. Genes Chromosomes Cancer 2006;45:11-9.
34. Gemma A, Hosoya Y, Seike M, et al. Genomic structure of the human MAD2 gene and mutation analysis in human lung and breast cancers. Lung Cancer 2001;32:289-95.
35. Takahashi T, Haruki N, Nomoto S, et al. Identification of frequent impairment of the mitotic checkpoint and molecular analysis of the mitotic Checkpoint genes. hsMAD2 and p55CDC. in human lung cancers. Oncogene 1999;18:4295-300.